MétaCan
Menu
← Back to cohort
Record W6977034559 · doi:10.6084/m9.figshare.29209644

Patient, caregiver experiences in metastatic castration-resistant prostate cancer: insights from a multi-national survey

2025· dataset· en· W6977034559 on OpenAlexaboutno aff

Bibliographic record

VenueFigshare · 2025
Typedataset
Languageen
Field
Topic
Canadian institutionsnot available
Fundersnot available
KeywordsProstate cancerGenetic testingFamily caregiversCancerGenetic counselingProstateCaregiver burdenQuality of life (healthcare)Depression (economics)

Abstract

fetched live from OpenAlex

Patients with metastatic castration-resistant prostate cancer (mCRPC) and caregivers were surveyed to understand their attitudes, emotions, and experiences with the disease, its treatments, and their willingness to explore genetic testing. A non-interventional, cross-sectional, online, quantitative-qualitative survey was conducted from 17-February to 9March 2022 among patients (≥21-years old) with mCRPC (diagnosis for ≥3-months) and caregivers. A total of 221 patients with mCRPC and 159 caregivers from USA, France, Germany, Canada, Spain, China, and Brazil were surveyed. mCRPC impacts mood, emotional and mental health (50–77%), sleep (48–68%), career goals (48–80%), and social activities (46–65%). Primary symptoms/side effects are urination issues (trouble urinating: 33–60%; painful/burning urination: 32–50%, frequent urination: 27–50%) and sexual dysfunction (lower libido: 10–57%), which impact romantic relationships. Caregivers often spouses or partners, provide practical, financial, and emotional support, averaging 11 hours/week of providing care. Patients face high treatment and pill burden (7–12 pills/day) and prefer simpler treatment regimens. Hope motivates patients and genetic testing is one such avenue of hope. mCRPC is a life-changing diagnosis with physical, psychological, and financial burdens. By encouraging early genetic testing and fostering patient-centered conversation, HCPs can provide personalized care for optimized treatment outcomes in mCRPC. This study assessed the experiences of people living with metastatic castration-resistant prostate cancer (mCRPC) – a type of advanced prostate cancer that may not respond to certain treatments – and the caregivers who support such individuals. Researchers surveyed patients and caregivers in seven countries to better understand how mCRPC affects daily life and how they feel about treatments and genetic testing. The results showed that mCRPC has a major impact on many areas of life, including mood, mental health, sleep, career goals, and social activities. Common symptoms include problems with urination and trouble with sex, which also affect romantic relationships. Most caregivers were spouses or partners who provided both emotional and financial support, spending an average of 11 hours each week helping their loved ones. Patients take many pills daily and generally prefer simpler treatment routines. Despite the challenges, many patients remain hopeful, and some see genetic testing as a promising option for more personalized treatment. In conclusion, mCRPC affects physical health, mental well-being and finances of both patients and caregivers. Encouraging early genetic testing and supportive conversations between patients and healthcare providers may lead to better treatment experiences and outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Dataset · Consensus signal: none
Teacher disagreement score0.017
Threshold uncertainty score0.033

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.006
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0000.002
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.108
GPT teacher head0.348
Teacher spread0.241 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreDataset

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueFigshare→French-language works237,207→